Prof. Hilal A. Lashuel

Prof. Hilal A. Lashuel is the Research Development and Innovation Advisor to the Chairperson of Qatar Foundation and Executive Director of RDI at the Chairperson’s Office. He is also an Associate Professor at EPFL and directs the Laboratory of Molecular and Chemical Biology of Neurodegeneration, where his research focuses on protein misfolding and aggregation in neurodegenerative diseases, with the goal of developing novel diagnostics and therapies.   Prof. Lashuel earned his B.Sc. in Chemistry from the City University of New York and completed his Ph.D. at Texas A&M University and the Scripps Research Institute. His postdoctoral work took him to the Picower Institute, Harvard Medical School, and Brigham and Women’s Hospital before joining EPFL. He has held visiting roles at Stanford University and executive positions at Qatar Biomedical Research and Qatar Biobank. He has also served on advisory boards for Qatar Genome Project, Qatar Metabolic Institute, and the Qatar Cancer Research Partnership.   Prof. Lashuel is the founder and CEO of ND BioSciences SA, a biotech company focused on neurodegenerative diseases, and serves as an associate editor for npj Parkinson’s Disease. His extensive contributions include over 225 publications, nine patents, and more than 250 invited lectures, amassing over 29,000 citations with an h-index of 92. His research has been supported by Swiss, European, and U.S. agencies, private foundations, and collaborations with major pharma companies. Among his awards are the Takreem Foundation’s Scientific Achievement Award, the Kuwait Prize, and recognition as a Young Global Leader by the World Economic Forum.